Document is current
Any future updates will be listed below
-
Authors
Huang, Liangqian https://orcid.org/0000-0002-7146-0296
Agrawal, Trisha
Zhu, Guixin
Yu, Sixiang
Tao, Liming
Lin, JiaBei https://orcid.org/0000-0001-8863-1859
Marmorstein, Ronen https://orcid.org/0000-0003-4373-4752
Shorter, James
Yang, Xiaolu https://orcid.org/0000-0001-6755-7725
- License Information
-
More Information
Article History
Received: 21 December 2019
Accepted: 15 July 2021
First Online: 18 August 2021
Competing interests
: X.Y. is a founder and equity holder of Evergreen Therapeutics LLC, which received investments from Wealth Strategy Holding Limited. J.S. is a consultant for Dewpoint Therapeutics, Maze Therapeutics, Vivid Sciences, Korro Bio, and ADRx. The other authors declare no competing financial interests.
